Immunomodulatory properties of HLA-G in infectious diseases

Journal of Immunology Research

Volumn 2014, Issue , 2014, Pages

  Amiot, Laurence ^a,b,c,d   Vu, Nicolas ^a,b,c   Samson, Michel ^a,b,c  

^a INSERM   (France)

^b UNIVERSITÉ DE RENNES 1   (France)

^c UNIVERSITÉ DE RENNES 1   (France)

^d PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; HLA G ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 19; INTERLEUKIN 20; INTERLEUKIN 22; INTERLEUKIN 24; INTERLEUKIN 26; MESSENGER RNA; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; TUMOR NECROSIS FACTOR ALPHA; VIRUS PROTEIN;

ANTIBODY RESPONSE; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; BACTERIAL INFECTION; CELL MIGRATION; CELL SURFACE; CYTOKINE RESPONSE; CYTOLYSIS; DOWN REGULATION; FEBRILE NEUTROPENIA; FIBROBLAST; GENE FREQUENCY; GENETIC RISK; GENETIC TRANSCRIPTION; GENOTYPE; HAPLOTYPE; HEPATITIS B; HEPATITIS C; HERPES SIMPLEX VIRUS 1; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOMOZYGOSITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOSTIMULATION; INFLAMMATION; INFLUENZA VIRUS A; LEISHMANIA INFANTUM; MACROPHAGE; MONOCYTE; NATURAL KILLER CELL; NONHUMAN; PARASITOSIS; PLASMODIUM FALCIPARUM; POLYMORPHONUCLEAR CELL; REGULATORY T LYMPHOCYTE; REVIEW; SEPTIC SHOCK; SINGLE NUCLEOTIDE POLYMORPHISM; T LYMPHOCYTE; TH1 CELL; TH2 CELL; TOXOPLASMA GONDII; UPREGULATION; VERTICAL TRANSMISSION; VIRUS INFECTION; VIRUS REPLICATION; VISCERAL LEISHMANIASIS; WART VIRUS; COMMUNICABLE DISEASE; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY;

COMMUNICABLE DISEASES; GENE EXPRESSION REGULATION; HLA-G ANTIGENS; HUMANS; IMMUNOMODULATION;

EID: 84900304868     PISSN: 23148861     EISSN: 23147156     Source Type: Journal    
DOI: 10.1155/2014/298569     Document Type: Review

References (122)

1. Geraghty D. E., Koller B. H., Orr H. T., A human major histocompatibility complex class I gene that encodes a protein with a shortened cytoplasmic segment. Proceedings of the National Academy of Sciences of the United States of America 1987 84 24 9145 9149 2-s2.0-0023475627
2. Mizuno S., Trapani J. A., Koller B. H., Dupont B., Yang S. Y., Isolation and nucleotide sequence of a cDNA clone encoding a novel HLA class I gene. Journal of Immunology 1988 140 11 4024 4030 2-s2.0-0023879564
3. Geraghty D. E., Wei X., Orr H. T., Koller B. H., Human leukocyte antigen F (HLA-F). An expressed HLA gene composed of a class I coding sequence linked to a novel transcribed repetitive element. The Journal of Experimental Medicine 1990 171 1 1 18 2-s2.0-0025139731 10.1084/jem.171.1.1 (Pubitemid 20040595)
4. Ishitani A., Geraghty D. E., Alternative splicing of HLA-G transcripts yields proteins with primary structures resembling both class I and class II antigens. Proceedings of the National Academy of Sciences of the United States of America 1992 89 9 3947 3951 2-s2.0-0026575821
5. Kirszenbaum M., Moreau P., Gluckman E., Dausset J., Carosella E., An alternatively spliced form of HLA-G mRNA in human trophoblasts and evidence for the presence of HLA-G transcript in adult lymphocytes. Proceedings of the National Academy of Sciences of the United States of America 1994 91 10 4209 4213 2-s2.0-0028346019 (Pubitemid 24143402)
6. Carosella E. D., Favier B., Rouas-Freiss N., Moreau P., Lemaoult J., Beyond the increasing complexity of the immunomodulatory HLA-G molecule. Blood 2008 111 10 4862 4870 2-s2.0-46749123555 10.1182/blood-2007-12-127662
7. Fujii T., Ishitani A., Geraghty D. E., A soluble form of the HLA-G antigen is encoded by a messenger ribonucleic acid containing intron 4. Journal of Immunology 1994 153 12 5516 5524 2-s2.0-0028116211 (Pubitemid 24377687)
8. Park G. M., Lee S., Park B., Kim E., Shin J., Cho K., Ahn K., Soluble HLA-G generated by proteolytic shedding inhibits NK-mediated cell lysis. Biochemical and Biophysical Research Communications 2004 313 3 606 611 2-s2.0-0346433828 10.1016/j.bbrc.2003.11.153 (Pubitemid 38021873)
9. Paul P., Adrian Cabestre F., Ibrahim E. C., Lefebvre S., Khalil-Daher I., Vazeux G., Moya Quiles R. M., Bermond F., Dausset J., Carosella E. D., Identification of HLA-G7 as a new splice variant of the HLA-G mRNA and expression of soluble HLA-G5, -G6, and -G7 transcripts in human transfected cells. Human Immunology 2000 61 11 1138 1149 2-s2.0-0034516969 10.1016/S0198-8859(00)00197-X (Pubitemid 32043892)
10. Moreau P., Carosella E., Teyssier M., Prost S., Gluckman E., Dausset J., Kirszenbaum M., Soluble HLA-G molecule: an alternatively spliced HLA-G mRNA form candidate to encode it in peripheral blood mononuclear cells and human trophoblasts. Human Immunology 1995 43 3 231 236 2-s2.0-0029089948 10.1016/0198-8859(95)00009-S
11. Morales P. J., Pace J. L., Platt J. S., Langat D. K., Hunt J. S., Synthesis of β 2-microglobulin-free, disulphide-linked HLA-G5 homodimers in human placental villous cytotrophoblast cells. Immunology 2007 122 2 179 188 2-s2.0-34447545098 10.1111/j.1365-2567.2007.02623.x (Pubitemid 47389946)
12. Howangyin K. Y., Loustau M., Wu J., Multimeric structures of HLA-G isoforms function through differential binding to LILRB receptors. Cellular and Molecular Life Sciences 2012 69 4041 4049
13. Gonen-Gross T., Achdout H., Gazit R., Hanna J., Mizrahi S., Markel G., Goldman-Wohl D., Yagel S., Hořejší V., Levy O., Baniyash M., Mandelboim O., Complexes of HLA-G protein on the cell surface are important for leukocyte Ig-like receptor-1 function. Journal of Immunology 2003 171 3 1343 1351 2-s2.0-0041845115 (Pubitemid 36900066)
14. Kirszenbaum M., Djoulah S., Hors J., Prost S., Dausset J., Carosella E. D., Polymorphism of HLA-G gene and protein. Journal of Reproductive Immunology 1999 43 2 105 109 2-s2.0-0032776085 10.1016/S0165-0378(99)00025-X (Pubitemid 29349675)
15. Donadi E. A., Castelli E. C., Arnaiz-Villena A., Roger M., Rey D., Moreau P., Implications of the polymorphism of HLA-G on its function, regulation, evolution and disease association. Cellular and Molecular Life Sciences 2011 68 3 369 395 2-s2.0-79951550728 10.1007/s00018-010-0580-7
16. Carosella E. D., Moreau P., LeMaoult J., Rouas-Freiss N., HLA-G: from biology to clinical benefits. Trends in Immunology 2008 29 3 125 132 2-s2.0-39949083940 10.1016/j.it.2007.11.005
17. Gobin S. J. P., van den Elsen P. J., Transcriptional regulation of the MHC class Ib genes HLA-E, HLA-F and HLA-G. Human Immunology 2000 61 11 1102 1107 2-s2.0-0034502106 10.1016/S0198-8859(00)00198-1 (Pubitemid 32043886)
18. Gonzalez A., Rebmann V., leMaoult J., Horn P. A., Carosella E. D., Alegre E., The immunosuppressive molecule HLA-G and its clinical implications. Critical Reviews in Clinical Laboratory Sciences 2012 49 63 84
19. Manaster I., Goldman-Wohl D., Greenfield C., Nachmani D., Tsukerman P., Hamani Y., Yagel S., Mandelboim O., MiRNA-mediated control of HLA-G expression and function. PLoS ONE 2012 7 3 2-s2.0-84858416153 10.1371/journal.pone.0033395 e33395
20. Moreau P., Flajollet S., Carosella E. D., Non-classical transcriptional regulation of HLA-G: an update. Journal of Cellular and Molecular Medicine 2009 13 9 2973 2989 2-s2.0-77449101343 10.1111/j.1582-4934.2009.00800.x
21. Kovats S., Main E. K., Librach C., Stubblebine M., Fisher S. J., Demars R., A class I antigen, HLA-G, expressed in human trophoblasts. Science 1990 248 4952 220 223 2-s2.0-0025706374 (Pubitemid 120031455)
22. le Discorde M., Moreau P., Sabatier P., Legeais J.-M., Carosella E. D., Expression of HLA-G in Human Cornea, an Immune-Privileged Tissue. Human Immunology 2003 64 11 1039 1044 2-s2.0-0242609915 10.1016/j.humimm.2003.08.346 (Pubitemid 37413712)
23. Mallet V., Fournel S., Schmitt C., Campan A., Lenfant F., le Bouteiller P., Primary cultured human thymic epithelial cells express both membrane-bound and soluble HLA-G translated products. Journal of Reproductive Immunology 1999 43 2 225 234 2-s2.0-0032776847 10.1016/S0165-0378(99)00036-4 (Pubitemid 29349686)
24. Ito T., Ito N., Saathoff M., Stampachiacchiere B., Bettermann A., Bulfone-Paus S., Takigawa M., Nickoloff B. J., Paus R., Immunology of the human nail apparatus: the nail matrix is a site of relative immune privilege. The Journal of Investigative Dermatology 2005 125 6 1139 1148 2-s2.0-33644818887 10.1111/j.0022-202X.2005.23927.x
25. Cirulli V., Zalatan J., McMaster M., Prinsen R., Salomon D. R., Ricordi C., Torbett B. E., Meda P., Crisa L., The class I HLA repertoire of pancreatic islets comprises the nonclassical class Ib antigen HLA-G. Diabetes 2006 55 5 1214 1222 2-s2.0-33745295348 10.2337/db05-0731 (Pubitemid 44195357)
26. + regulatory T cells. Stem Cells 2008 26 1 212 222 2-s2.0-38349053355 10.1634/stemcells.2007-0554
27. Menier C., Rabreau M., Challier J.-C., le Discorde M., Carosella E. D., Rouas-Freiss N., Erythroblasts secrete the nonclassical HLA-G molecule from primitive to definitive hematopoiesis. Blood 2004 104 10 3153 3160 2-s2.0-8644289450 10.1182/blood-2004-03-0809 (Pubitemid 39507129)
28. Colonna M., Navarro F., Bellón T., Llano M., García P., Samaridis J., Angman L., Cella M., López-Botet M., A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells. The Journal of Experimental Medicine 1997 186 11 1809 1818 2-s2.0-0030819308 10.1084/jem.186.11.1809 (Pubitemid 27524591)
29. Colonna M., Samaridis J., Cella M., Angman L., Allen R. L., O'Callaghan C. A., Dunbar R., Ogg G. S., Cerundolo V., Rolink A., Cutting edge: human myelomonocytic cells express an inhibitory receptor for classical and nonclassical MHC class I-molecules. Journal of Immunology 1998 160 7 3096 3100 2-s2.0-0032036434 (Pubitemid 28164696)
30. Faure M., Long E. O., KIR2DL4 (CD158d), an NK cell-activating receptor with inhibitory potential. Journal of Immunology 2002 168 12 6208 6214 2-s2.0-0037097664 (Pubitemid 34620040)
31. Rajagopalan S., Long E. O., A human histocompatibility leukocyte antigen (HLA)-G-specific receptor expressed on all natural killer cells. The Journal of Experimental Medicine 1999 189 7 1093 1099 2-s2.0-0033526056 10.1084/jem.189.7.1093 (Pubitemid 29169826)
32. Fournel S., Aguerre-Girr M., Huc X., Lenfant F., Alam A., Toubert A., Bensussan A., Le Bouteiller P., Cutting edge: soluble HLA-G1 triggers CD95/CD95 ligand-mediated apoptosis in activated CD8+ cells by interacting with CD8. Journal of Immunology 2000 164 12 6100 6104 2-s2.0-0034660339 (Pubitemid 30408785)
33. Gros F., Cabillic F., Tourirais O., le Maux A., Sebti Y., Amiot L., Soluble HLA-G molecules impair natural killer/dendritic cell crosstalk via inhibition of dendritic cells. European Journal of Immunology 2008 38 3 742 749 2-s2.0-43649104999 10.1002/eji.200736918
34. Horuzsko A., Lenfant F., Munn D. H., Mellor A. L., Maturation of antigen-presenting cells is compromised in HLA-G transgenic mice. International Immunology 2001 13 3 385 394 2-s2.0-0035111307 (Pubitemid 32179087)
35. le Friec G., Gros F., Sebti Y., Guilloux V., Pangault C., Fauchet R., Amiot L., Capacity of myeloid and plasmacytoid dendritic cells especially at mature stage to express and secrete HLA-G molecules. Journal of Leukocyte Biology 2004 76 6 1125 1133 2-s2.0-10044268790 10.1189/jlb.0104015 (Pubitemid 39602948)
36. Le Friec G., Laupèze B., Fardel O., Sebti Y., Pangault C., Guilloux V., Beauplet A., Fauchet R., Amiot L., Soluble HLA-G inhibits human dendritic cell-triggered allogeneic T-cell proliferation without altering dendritic differentiation and maturation processes. Human Immunology 2003 64 8 752 761 2-s2.0-0042209924 10.1016/S0198-8859(03)00091-0 (Pubitemid 36927638)
37. le Gal F.-A., Riteau B., Sedlik C., Khalil-Daher I., Menier C., Dausset J., Guillet J.-G., Carosella E. D., Rouas-Freiss N., HLA-G-mediated inhibition of antigen-specific cytotoxic T lymphocytes. International Immunology 1999 11 8 1351 1356 2-s2.0-0032788734 10.1093/intimm/11.8.1351 (Pubitemid 29355674)
38. Rouas-Freiss N., Gonçalves R. M.-B., Menier C., Dausset J., Carosella E. D., Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis. Proceedings of the National Academy of Sciences of the United States of America 1997 94 21 11520 11525 2-s2.0-0030848809 10.1073/pnas.94.21.11520 (Pubitemid 27451031)
39. Naji A., Menier C., Maki G., Carosella E. D., Rouas-Freiss N., Neoplastic B-cell growth is impaired by HLA-G/ILT2 interaction. Leukemia 2012 26 1889 1892 2-s2.0-84858737614 10.1038/leu.2012.62
40. + T cell regulatory mechanism. Proceedings of the National Academy of Sciences of the United States of America 2001 98 21 12150 12155 2-s2.0-0035834060 10.1073/pnas.201407398 (Pubitemid 32959842)
41. Naji A., Durrbach A., Carosella E. D., Rouas-Freiss N., Soluble HLA-G and HLA-G1 expressing antigen-presenting cells inhibit T-cell alloproliferation through ILT-2/ILT-4/fasL-mediated pathways. Human Immunology 2007 68 4 233 239 2-s2.0-33947657929 10.1016/j.humimm.2006.10.017 (Pubitemid 46497518)
42. Carosella E. D., Gregori S., LeMaoult J., The tolerogenic interplay(s) among HLA-G, myeloid APCs, and regulatory cells. Blood 2011 118 25 6499 6505 2-s2.0-84055218980 10.1182/blood-2011-07-370742
43. LeMaoult J., Caumartin J., Daouya M., Favier B., Le Rond S., Gonzalez A., Carosella E. D., Immune regulation by pretenders: cell-to-cell transfers of HLA-G make effector T cells act as regulatory cells. Blood 2007 109 5 2040 2048 2-s2.0-33847340782 10.1182/blood-2006-05-024547 (Pubitemid 46348204)
44. Baudhuin J., Migraine J., Faivre V., Loumagne L., Lukaszewicz A. C., Payen D., Favier B., Exocytosis acts as a modulator of the ILT4-mediated inhibition of neutrophil functions. Proceedings of the National Academy of Sciences of the United States of America 2013 110 17957 17962
45. Amiot L., Ferrone S., Grosse-Wilde H., Seliger B., Biology of HLA-G in cancer: a candidate molecule for therapeutic intervention? Cellular and Molecular Life Sciences 2011 68 3 417 431 2-s2.0-79951549780 10.1007/s00018-010-0583-4
46. Reddy R. C., Chen G. H., Tekchandani P. K., Standiford T. J., Sepsis-induced immunosuppression: from bad to worse. Immunologic Research 2001 24 3 273 287 2-s2.0-0035172366 10.1385/IR:24:3:273 (Pubitemid 33064386)
47. Monneret G., Voirin N., Krawice-Radanne I., Bohé J., Lepape A., Rouas-Freiss N., Carosella E. D., Soluble human leukocyte antigen-G5 in septic shock: marked and persisting elevation as a predictor of survival. Critical Care Medicine 2007 35 8 1942 1947 2-s2.0-34547652673 10.1097/01.CCM.0000277039. 84372.1C (Pubitemid 47220370)
48. Urbonas V., Eidukaite A., Tamuliene I., The predictive value of soluble biomarkers (CD14 subtype, interleukin-2 receptor, human leucocyte antigen-G) and procalcitonin in the detection of bacteremia and sepsis in pediatric oncology patients with chemotherapy-induced febrile neutropenia. Cytokine 2013 62 34 37
49. Sabbagh A., Courtin D., Milet J., Massaro J. D., Castelli E. C., Migot-Nabias F., Favier B., Rouas-Freiss N., Moreau P., Garcia A., Donadi E. A., Association of HLA-G 3′ untranslated region polymorphisms with antibody response against Plasmodium falciparum antigens: preliminary results. Tissue Antigens 2013 82 53 58
50. Donaghy L., Gros F., Amiot L., Mary C., Maillard A., Guiguen C., Gangneux J.-P., Elevated levels of soluble non-classical major histocompatibility class I molecule human leucocyte antigen (HLA)-G in the blood of HIV-infected patients with or without visceral leishmaniasis. Clinical and Experimental Immunology 2007 147 2 236 240 2-s2.0-33846251260 10.1111/j.1365-2249.2006.03268.x (Pubitemid 46096000)
51. Gangneux J. P., Poinsignon Y., Donaghy L., Amiot L., Tarte K., Mary C., Robert-Gangneux F., Indoleamine 2,3-dioxygenase activity as a potential biomarker of immune suppression during visceral leishmaniasis. Innate Immunity 2013 19 564 568
52. Robert-Gangneux F., Gangneux J.-P., Vu N., Jaillard S., Guiguen C., Amiot L., High level of soluble HLA-G in amniotic fluid is correlated with congenital transmission of Toxoplasma gondii. Clinical Immunology 2011 138 2 129 134 2-s2.0-79251597891 10.1016/j.clim.2010.12.004
53. Zhao M., Zhang R., Xu X., Liu Y., Zhang H., Zhai X., Hu X., IL-10 reduces levels of apoptosis in Toxoplasma gondii -infected trophoblasts. PloS ONE 2013 8 e56455
54. Murdaca G., Contini P., Setti M., Cagnati P., Lantieri F., Indiveri F., Puppo F., Behavior of non-classical soluble HLA class G antigens in human immunodeficiency virus 1-infected patients before and after HAART: comparison with classical soluble HLA-A, -B, -C antigens and potential role in immune-reconstitution. Clinical Immunology 2009 133 2 238 244 2-s2.0-70349785082 10.1016/j.clim.2009.08.002
55. Huang J., Burke P., Yang Y., Seiss K., Beamon J., Cung T., Toth I., Pereyra F., Lichterfeld M., Yu X. G., Soluble HLA-G inhibits myeloid dendritic cell function in HIV-1 infection by interacting with leukocyte immunoglobulin-like receptor B2. Journal of Virology 2010 84 20 10784 10791 2-s2.0-77957205103 10.1128/JVI.01292-10
56. Cabello A., Rivero A., Garcia M. J., Lozano J. M., Torre-Cisneros J., González R., Dueñas G., Galiani M. D., Camacho A., Santamaria M., Solana R., Montero C., Kindelán J. M., Peña J., HAART induces the expression of HLA-G on peripheral monocytes in HIV-1 infected individuals. Human Immunology 2003 64 11 1045 1049 2-s2.0-0242525170 10.1016/j.humimm.2003.08.353 (Pubitemid 37413713)
57. Lozano J. M., González R., Kindelán J. M., Rouas-Freiss N., Caballos R., Dausset J., Carosella E. D., Peña J., Monocytes and T lymphocytes in HIV-1-positive patients express HLA-G molecule. AIDS 2002 16 3 347 351 2-s2.0-0037083937 10.1097/00002030-200202150-00005 (Pubitemid 34165365)
58. Rivero A., Lozano J. M., González R., García-Jurado G., Camacho A., Torres-Cisneros J., Peña J., Nucleoside reverse transcriptase inhibitors are able and protease inhibitors unable to induce the tolerogenic molecule HLA-G1 on monocytes from HIV-1 infected patients. Human Immunology 2007 68 4 303 306 2-s2.0-33947670478 10.1016/j.humimm.2006.10.014 (Pubitemid 46497517)
59. Murdaca G., Contini P., Setti M., Cagnati P., Spanò F., Lantieri F., Puppo F., Soluble human leukocyte antigen-G serum levels in patients with acquired immune deficiency syndrome affected by different disease-defining conditions before and after antiretroviral treatment. Human Immunology 2011 72 9 712 716 2-s2.0-84860390732 10.1016/j.humimm.2011.05.008
60. Li C., Toth I., Schulze zur Wiesch J., Pereyra F., Rychert J., Rosenberg E. S., van Lunzen J., Lichterfeld M., Yu X. G., Functional characterization of HLA-G(+) regulatory T cells in HIV-1 infection. PLoS Pathogens 2013 9 e1003140
61. Onno M., Pangault C., le Friec G., Guilloux V., André P., Fauchetz R., Modulation of HLA-G antigens expression by human cytomegalovirus: specific induction in activated macrophages harboring human cytomegalovirus infection. Journal of Immunology 2000 164 12 6426 6434 2-s2.0-0034659769 (Pubitemid 30408825)
62. Yan W.-H., Lin A., Chen B.-G., Chen S.-Y., Induction of both membrane-bound and soluble HLA-G expression in active human cytomegalovirus infection. The Journal of Infectious Diseases 2009 200 5 820 826 2-s2.0-70349316715 10.1086/604733
63. Lafon M., Prehaud C., Megret F., Lafage M., Mouillot G., Roa M., Moreau P., Rouas-Freiss N., Carosella E. D., Modulation of HLA-G expression in human neural cells after neurotropic viral infections. Journal of Virology 2005 79 24 15226 15237 2-s2.0-29744455502 10.1128/JVI.79.24.15226-15237.2005 (Pubitemid 43032305)
64. Mégret F., Prehaud C., Lafage M., Moreau P., Rouas-Freiss N., Carosella E. D., Lafon M., Modulation of HLA-G and HLA-E expression in human neuronal cells after rabies virus or herpes virus simplex type 1 infections. Human Immunology 2007 68 4 294 302 2-s2.0-33947643134 10.1016/j.humimm.2006.12. 003 (Pubitemid 46497524)
65. LeBouder F., Khoufache K., Menier C., Mandouri Y., Keffous M., Lejal N., Krawice-Radanne I., Carosella E. D., Rouas-Freiss N., Riteau B., Immunosuppressive HLA-G molecule is upregulated in alveolar epithelial cells after influenza A virus infection. Human Immunology 2009 70 12 1016 1019 2-s2.0-70449519161 10.1016/j.humimm.2009.07.026
66. Chen H.-X., Chen B.-G., Shi W.-W., Zhen R., Xu D.-P., Lin A., Yan W.-H., Induction of cell surface human leukocyte antigen-G expression in pandemic H1N1 2009 and seasonal H1N1 influenza virus-infected patients. Human Immunology 2011 72 2 159 165 2-s2.0-78651232818 10.1016/j.humimm.2010.11.009
67. Guimarães M. C. M., Soares C. P., Donadi E. A., Derchain S. F. M., Andrade L. A. L. A., Silva T. G. A., Hassumi M. K., Simões R. T., Miranda F. A., Lira R. C. P., Crispim J., Soares E. G., Low expression of human histocompatibility soluble leukocyte antigen-G (HLA-G5) in invasive cervical cancer with and without metastasis, associated with papilloma virus (HPV). The Journal of Histochemistry and Cytochemistry 2010 58 5 405 411 2-s2.0-77951908342 10.1369/jhc.2009.954131
68. Shi W.-W., Lin A., Xu D.-P., Bao W.-G., Zhang J.-G., Chen S.-Y., Li J., Yan W.-H., Plasma soluble human leukocyte antigen-G expression is a potential clinical biomarker in patients with hepatitis B virus infection. Human Immunology 2011 72 11 1068 1073 2-s2.0-80054108228 10.1016/j.humimm.2011.06.012
69. Weng P.-J., Fu Y.-M., Ding S.-X., Xu D.-P., Lin A., Yan W.-H., Elevation of plasma soluble human leukocyte antigen-G in patients with chronic hepatitis C virus infection. Human Immunology 2011 72 5 406 411 2-s2.0-79954577776 10.1016/j.humimm.2011.02.008
70. Souto F. J. D., Crispim J. C. O., Ferreira S. C., Da Silva A. S. M., Bassi C. L., Soares C. P., Zucoloto S., Rouas-Freiss N., Moreau P., Martinelli A. L. C., Donadi E. A., Liver HLA-G expression is associated with multiple clinical and histopathological forms of chronic hepatitis B virus infection. Journal of Viral Hepatitis 2011 18 2 102 105 2-s2.0-78751503364 10.1111/j.1365-2893.2010.01286.x
71. Amiot L., Vu N., Rauch M., Expression of HLA-G by mast cells is associated with hepatitis C virus-induced liver fibrosis. Journal of Hepatology 2014 60 245 252
72. Matte C., Lajoie J., Lacaille J., Zijenah L. S., Ward B. J., Roger M., Functionally active HLA-G polymorphisms are associated with the risk of heterosexual HIV-1 infection in African women. AIDS 2004 18 3 427 431 2-s2.0-1642300418 10.1097/00002030-200402200-00008 (Pubitemid 38365869)
73. Lajoie J., Hargrove J., Zijenah L. S., Humphrey J. H., Ward B. J., Roger M., Genetic variants in nonclassical major histocompatibility complex class I human leukocyte antigen (HLA)-E and HLA-G molecules are associated with susceptibility to heterosexual acquisition of HIV-1. The Journal of Infectious Diseases 2006 193 2 298 301 2-s2.0-30944442246 10.1086/498877 (Pubitemid 43113493)
74. Segat L., Catamo E., Fabris A., Morgutti M., D'Agaro P., Campello C., Crovella S., HLA-G 0105N allele is associated with augmented risk for HIV infection in white female patients. AIDS 2010 24 12 1961 1964 2-s2.0-77954761518 10.1097/QAD.0b013e32833c3324
75. da Silva G. K., Vianna P., Veit T. D., Crovella S., Catamo E., Cordero E. A., Mattevi V. S., Lazzaretti R. K., Sprinz E., Kuhmmer R., Chies J. A., Influence of HLA-G polymorphisms in human immunodeficiency virus infection and hepatitis C virus co-infection in Brazilian and Italian individuals. Infection, genetics and evolution. Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases 2014 21 418 423
76. Aikhionbare F. O., Kumaresan K., Shamsa F., Bond V. C., HLA-G DNA sequence variants and risk of perinatal HIV-I transmission. AIDS Research and Therapy 2006 3 1, article 28 2-s2.0-33750945458 10.1186/1742-6405-3-28 (Pubitemid 44734195)
77. Luo M., Czarnecki C., Ramdahin S., Embree J., Plummer F. A., HLA-G and mother-child perinatal HIV transmission. Human Immunology 2013 74 459 463
78. Castelli E. C., Moreau P., Chiromatzo A. O. E., Mendes-Junior C. T., Veiga-Castelli L. C., Yaghi L., Giuliatti S., Carosella E. D., Donadi E. A., In silico analysis of microRNAS targeting the HLA-G 3′ untranslated region alleles and haplotypes. Human Immunology 2009 70 12 1020 1025 2-s2.0-70350702674 10.1016/j.humimm.2009.07.028
79. Cordero E. A. A., Veit T. D., da Silva M. A. L., Jacques S. M. C., Silla L. M. D. R., Chies J. A. B., HLA-G polymorphism influences the susceptibility to HCV infection in sickle cell disease patients. Tissue Antigens 2009 74 4 308 313 2-s2.0-70349337710 10.1111/j.1399-0039.2009.01331.x
80. Martinetti M., Pacati I., Cuccia M., Badulli C., Pasi A., Salvaneschi L., Minola E., De Silvestri A., Iannone A. M., Maccabruni A., Hierarchy of baby-linked immunogenetic risk factors in the vertical transmission of hepatitis C virus. International Journal of Immunopathology and Pharmacology 2006 19 2 369 378 2-s2.0-33746815268 (Pubitemid 44181959)
81. Zheng X.-Q., Zhu F., Shi W.-W., Lin A., Yan W.-H., The HLA-G 14 bp insertion/deletion polymorphism is a putative susceptible factor for active human cytomegalovirus infection in children. Tissue Antigens 2009 74 4 317 321 2-s2.0-70349320395 10.1111/j.1399-0039.2009.01312.x
82. Bortolotti D., Gentili V., Rotola A., di Luca D., Rizzo R., Implication of HLA-G 3′ untranslated region polymorphisms in human papillomavirus infection. Tissue Antigens 2014 83 113 118
83. Garcia A., Milet J., Courtin D., Sabbagh A., Massaro J. D., Castelli E. C., Migot-Nabias F., Favier B., Rouas-Freiss N., Donadi E. A., Moreau P., Association of HLA-G 3′UTR polymorphisms with response to malaria infection: a first insight. Infection, genetics and evolution. Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases 2013 16 263 269
84. Barel M. T., Ressing M., Pizzato N., van Leeuwen D., le Bouteiller P., Lenfant F., Wiertz E. J. H. J., Human cytomegalovirus-encoded US2 differentially affects surface expression of MHC class I locus products and targets membrane-bound, but not soluble HLA-G1 GL for degradation. Journal of Immunology 2003 171 12 6757 6765 2-s2.0-0345735830 (Pubitemid 37532109)
85. Pizzato N., Derrien M., Lenfant F., The short cytoplasmic tail of HLA-G determines its resistance to HIV-1 Nef-mediated cell surface downregulation. Human Immunology 2004 65 11 1389 1396 2-s2.0-8844284445 10.1016/j.humimm.2004. 07.239 (Pubitemid 39535301)
86. Schust D. J., Tortorella D., Seebach J., Phan C., Bacik I., Bennink J. R., Yewdell J. W., Ploegh H. L., Trophoblast class I major histocompatibility complex (MHC)4 products are resistant to rapid degradation imposed by the human cytomegalovirus (HCMV) gene products US2 and US11. The Journal of Experimental Medicine 1998 188 497 503 2-s2.0-0033526801 (Pubitemid 28369139)
87. Jun Y., Kim E., Jin M., Sung H. C., Han B., Geraghty D. E., Ahn K., Human cytomegalovirus gene products US3 and US6 down-regulate trophoblast class I MHC molecules. Journal of Immunology 2000 164 2 805 811 2-s2.0-0034650691 (Pubitemid 30043704)
88. Park B., Spooner E., Houser B. L., Strominger J. L., Ploegh H. L., The HCMV membrane glycoprotein US10 selectively targets HLA-G for degradation. The Journal of Experimental Medicine 2010 207 9 2033 2041 2-s2.0-77956255311 10.1084/jem.20091793
89. Pizzato N., Garmy-Susini B., le Bouteiller P., Lenfant F., Down-regulation of HLA-G1 cell surface expression in human cytomegalovirus infected cells. American Journal of Reproductive Immunology 2003 50 4 328 333 2-s2.0-0141793973 10.1034/j.1600-0897.2003.00087.x (Pubitemid 37203576)
90. Schust D. J., Hill A. B., Ploegh H. L., Herpes simplex virus blocks intracellular transport of HLA-G in placentally derived human cells. Journal of Immunology 1996 157 8 3375 3380 2-s2.0-0030587901 (Pubitemid 126449149)
91. Pizzato N., Garmy-Susini B., Bouteiller P. L., Lenfant F., Differential down-modulation of HLA-G and HLA-A2 or -A3 cell surface expression following human cytomegalovirus infection. Journal of Reproductive Immunology 2004 62 1-2 3 15 2-s2.0-3342977792 10.1016/j.jri.2003.11.005 (Pubitemid 38993265)
92. le Gall S., Buseyne F., Trocha A., Walker B. D., Heard J.-M., Schwartz O., Distinct trafficking pathways mediate Nef-induced and clathrin-dependent major histocompatibility complex class I down-regulation. Journal of Virology 2000 74 19 9256 9266 2-s2.0-0033798906 10.1128/JVI.74.19.9256-9266.2000
93. Ouyang W., Rutz S., Crellin N. K., Valdez P. A., Hymowitz S. G., Regulation and functions of the IL-10 family of cytokines in inflammation and disease. Annual Review of Immunology 2011 29 71 109 2-s2.0-79953048089 10.1146/annurev-immunol-031210-101312
94. Marie C., Muret J., Fitting C., Losser M.-R., Payen D., Cavaillon J.-M., Reduced ex vivo interleukin-8 production by neutrophils in septic and nonseptic systemic inflammatory response syndrome. Blood 1998 91 9 3439 3446 2-s2.0-0032079326 (Pubitemid 28193897)
95. Urbonas V., Eidukaitë A., Tamulienë I., Increased interleukin-10 levels correlate with bacteremia and sepsis in febrile neutropenia pediatric oncology patients. Cytokine 2012 57 3 313 315 2-s2.0-84856374701 10.1016/j.cyto.2011.11.012
96. Moore K. W., de Waal Malefyt R., Coffman R. L., O'Garra A., Interleukin-10 and the interleukin-10 receptor. Annual Review of Immunology 2001 19 683 765 2-s2.0-0035062021 10.1146/annurev.immunol.19.1.683 (Pubitemid 32368050)
97. Moreau P., Adrian-Cabestre F., Menier C., Guiard V., Gourand L., Dausset J., Carosella E. D., Paul P., IL-10 selectively induces HLA-G expression in human trophoblasts and monocytes. International Immunology 1999 11 5 803 811 2-s2.0-0032913576 10.1093/intimm/11.5.803 (Pubitemid 29237771)
98. Yang Y., Geraghty D. E., Hunt J. S., Cytokine regulation of HLA-G expression in human trophoblast cell lines. Journal of Reproductive Immunology 1995 29 3 179 195 2-s2.0-0028844753 10.1016/0165-0378(95)00942-E
99. Onno M., le Friec G., Pangault C., Amiot L., Guilloux V., Drénou B., Caulet-Maugendre S., André P., Fauchet R., Modulation of HLA-G antigens expression in myelomonocytic cells. Human Immunology 2000 61 11 1086 1094 2-s2.0-0034509291 10.1016/S0198-8859(00)00191-9 (Pubitemid 32043884)
100. Zilberman S., Schenowitz C., Agaugue S., Benoit F., Riteau B., Rouzier R., Carosella E. D., Rouas-Freiss N., Menier C., HLA-G1 and HLA-G5 active dimers are present in malignant cells and effusions: the influence of the tumor microenvironment. European Journal of Immunology 2012 42 1599 1608
101. Ugurel S., Rebmann V., Ferrone S., Tilgen W., Grosse-Wilde H., Reinhold U., Soluble human leukocyte antigen-G serum level is elevated in melanoma patients and is further increased by interferon-alpha immunotherapy. Cancer 2001 92 369 376 (Pubitemid 32664444)
102. Mitsdoerffer M., Schreiner B., Kieseier B. C., Neuhaus O., Dichgans J., Hartung H.-P., Weller M., Wiendl H., Monocyte-derived HLA-G acts as a strong inhibitor of autologous CD4 T cell activation and is upregulated by interferon- β in vitro and in vivo: rationale for the therapy of multiple sclerosis. Journal of Neuroimmunology 2005 159 1-2 155 164 2-s2.0-12344305533 10.1016/j.jneuroim.2004.09.016 (Pubitemid 40126188)
103. Lefebvre S., Berrih-Aknin S., Adrian F., Moreau P., Poea S., Gourand L., Dausset J., Carosella E. D., Paul P., A specific interferon (IFN)-stimulated response element of the distal HLA-G promoter binds IFN-regulatory factor 1 and mediates enhancement of this nonclassical class I gene by IFN- β Journal of Biological Chemistry 2001 276 9 6133 6139 2-s2.0-0035794210 10.1074/jbc.M008496200
104. Gupta P., Ghosh S., Nagarajan A., Mehta V. S., Sen E., Beta-defensin-3 negatively regulates TLR4-HMGB1 axis mediated HLA-G expression in IL-1beta treated glioma cells. Cellular Signalling 2013 25 682 689
105. Gruber B. L., Kew R. R., Jelaska A., Marchese M. J., Garlick J., Ren S., Schwartz L. B., Korn J. H., Human mast cells activate fibroblasts: tryptase is a fibrogenic factor stimulating collagen messenger ribonucleic acid synthesis and fibroblast chemotaxis. Journal of Immunology 1997 158 5 2310 2317 2-s2.0-0031091747 (Pubitemid 127470016)
106. Marvie P., Lisbonne M., L'Helgoualc'h A., Rauch M., Turlin B., Preisser L., Bourd-Boittin K., Théret N., Gascan H., Piquet-Pellorce C., Samson M., Interleukin-33 overexpression is associated with liver fibrosis in mice and humans. Journal of Cellular and Molecular Medicine 2010 14 6 B 1726 1739 2-s2.0-77955142252 10.1111/j.1582-4934.2009.00801.x
107. Allakhverdi Z., Smith D. E., Comeau M. R., Delespesse G., Cutting edge: the ST2 ligand IL-33 potently activates and drives maturation of human mast cells. Journal of Immunology 2007 179 4 2051 2054 2-s2.0-34848886843
108. Iikura M., Suto H., Kajiwara N., Oboki K., Ohno T., Okayama Y., Saito H., Galli S. J., Nakae S., IL-33 can promote survival, adhesion and cytokine production in human mast cells. Laboratory Investigation 2007 87 10 971 978 2-s2.0-34548719890 10.1038/labinvest.3700663 (Pubitemid 47429189)
109. Gruber B. L., Marchese M. J., Kew R. R., Transforming growth factor- β 1 mediates mast cell chemotaxis. Journal of Immunology 1994 152 12 5860 5867 2-s2.0-0028181253
110. Hsu C.-L., Neilsen C. V., Bryce P. J., IL-33 is produced by mast cells and regulates IgE-dependent inflammation. PLoS ONE 2010 5 8 2-s2.0-77957787918 10.1371/journal.pone.0011944 e11944
111. Grimbaldeston M. A., Nakae S., Kalesnikoff J., Tsai M., Galli S. J., Mast cell-derived interleukin 10 limits skin pathology in contact dermatitis and chronic irradiation with ultraviolet B. Nature Immunology 2007 8 10 1095 1104 2-s2.0-34548757393 10.1038/ni1503 (Pubitemid 47423757)
112. Morandi F., Ferretti E., Castriconi R., Dondero A., Petretto A., Bottino C., Pistoia V., Soluble HLA-G dampens CD94/NKG2A expression and function and differentially modulates chemotaxis and cytokine and chemokine secretion in CD 56bright and CD 56dim NK cells. Blood 2011 118 22 5840 5850 2-s2.0-82155184509 10.1182/blood-2011-05-352393
113. Wuest T. R., Carr D. J. J., Dysregulation of CXCR3 signaling due to CXCL10 deficiency impairs the antiviral response to herpes simplex virus 1 infection. Journal of Immunology 2008 181 11 7985 7993 2-s2.0-58149289898
114. Agaugué S., Carosella E. D., Rouas-Freiss N., Role of HLA-G in
115. Lin A., Zhang X., Xu H.-H., Xu D.-P., Ruan Y.-Y., Yan W.-H., HLA-G expression is associated with metastasis and poor survival in the Balb/c nu/nu murine tumor model with ovarian cancer. International Journal of Cancer 2012 131 1 150 157 2-s2.0-84860223684 10.1002/ijc.26375
116. LeMaoult J., Daouya M., Wu J., Loustau M., Horuzsko A., Carosella E. D., Synthetic HLA-G proteins for therapeutic use in transplantation. FASEB Journal 2013 27 3643 3651
117. Celsi F., Catamo E., Kleiner G., Tricarico P. M., Vuch J., Crovella S., HLA-G/C, miRNAs, and their role in HIV infection and replication. BioMed Research International 2013 2013 13 693643 10.1155/2013/693643
118. Sartelet H., Schleiermacher D., Le-Hesran J. Y., Graesslin O., Gaillard D., Fe M., Lechki C., Gaye A., Le Bouteiller P., Birembaut P., Less HLA-G expression in Plasmodium falciparum -infected third trimester placentas is associated with more natural killer cells. Placenta 2005 26 6 505 511 2-s2.0-20444364173 10.1016/j.placenta.2004.08.006 (Pubitemid 40796579)
119. Derrien M., Pizzato N., Dolcini G., Menu E., Chaouat G., Lenfant F., Barré-Sinoussi F., Le Bouteiller P., Human immunodeficiency virus 1 downregulates cell surface expression of the non-classical major histocompatibility class I molecule HLA-G1. The Journal of General Virology 2004 85 7 1945 1954 2-s2.0-3343019387 10.1099/vir.0.79867-0 (Pubitemid 39023273)
120. Lajoie J., Fontaine J., Tremblay C., Routy J.-P., Poudrier J., Roger M., Persistence of high levels of blood soluble human leukocyte antigen-G is associated with rapid progression of HIV infection. AIDS 2009 23 11 1437 1440 2-s2.0-68449093189 10.1097/QAD.0b013e32832d0825
121. de Oliveira Crispim J. C., Silva T. G. A., Souto F. J. D., Souza F. F., Bassi C. L., Soares C. P., Zucoloto S., Moreau P., Martinelli A. D. L. C., Donadi E. A., Upregulation of soluble and membrane-bound human leukocyte antigen G expression is primarily observed in the milder histopathological stages of chronic hepatitis C virus infection. Human Immunology 2012 73 3 258 262 2-s2.0-84857121050 10.1016/j.humimm.2011.12.004
122. Turk W. J., Kimani J., Bielawny T., Wachihi C., Ball T. B., Plummer F. A., Luo M., Associations of human leukocyte antigen-G with resistance and susceptibility to HIV-1 infection in the Pumwani sex worker cohort. AIDS 2013 27 7 15